INVESTOR NOTICE: Valeant Pharmaceuticals International Inc. (VRX) Listed on TSX & SIX.

TORONTO, Nov. 2, 2015 /CNW/ - Faguy & Co. (Montreal) and Morganti Legal (Toronto), announce that on Monday, October 26, 2015, they issued a class action claim in Quebec on behalf of all investors that purchased the securities of Valeant Pharmaceuticals International Inc. listed on the Toronto Stock Exchange and the Swiss Stock Exchange.  (TSX and SIX: "VRX").

Investors who purchased shares of Valeant Pharmaceuticals International Inc. on the Toronto Stock Exchange and Swiss Stock Exchange on or before October 21, 2015 are encouraged to stay informed and protect their rights. You may contact Morganti Legal at (888) 226-0845 or by email at or Faguy & Co. at (514) 285-8100 or by email at for further information.

None of the allegations have been adjudicated in court at this time.

Faguy & Co is a boutique commercial and civil litigation firm. It represents an international clientele and referring law firms worldwide in the jurisdictions of Quebec, Ontario and before the federal courts. To learn more about Faguy & Co. please visit

Morganti Legal is comprised of experienced securities lawyers that investigate, litigate and resolve economic and financial disputes. You may learn more about Morganti Legal at The Firm currently represents investors that purchased securities of Allied Nevada Gold Corp, BP plc, Detour Gold Corporation, Ithaca Energy Limited, MDC Partners, Inc., Silvercorp Metals Inc., and Tesco plc.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE Trilogy Class Actions

For further information: Shawn K. Faguy (French language) at (514) 285-8100 or by email at; Andrew Morganti, (English language) at (888) 226-0845 or by email at


Organization Profile

Trilogy Class Actions

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890